Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
PanAmerican Clinical Research and CAIMED partner for clinical site alliance
PanAmerican delivers clinical trial, home visit, and patient recruitment services. Credit: Olga Kononenko on Unsplash
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
esqLABS
Founded in 2017, esqLABS provides platform technologies, software, consulting and...
About
Founded in 2017, esqLABS provides platform technologies, software, consulting and workshops for data analysis and model-based decision support throughout the healthcare industry.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Cellular Technology Limited
Cellular Technology Limited (CTL) is a global biotechnology company specialized...
About
Cellular Technology Limited (CTL) is a global biotechnology company specialized in the development, use, and manufacture of standardized tools for cellular immune assays.
FollowMake an Enquiry